Temesgen Z - Search Results

1

Pharmacogenomic panel testing provides insight and enhances medication management in people with HIV.

Zeuli JD, Rivera CG, Wright JA, Kasten MJ, Mahmood M, Ragan AK, Rizza SA, Temesgen Z, Vergidis P, Wilson JW, Cummins NW. Zeuli JD, et al. Among authors: temesgen z. AIDS. 2023 Aug 1;37(10):1525-1533. doi: 10.1097/QAD.0000000000003598. Epub 2023 May 11. AIDS. 2023. PMID: 37199600

2

Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.

Cummins NW, Neuhaus J, Sainski AM, Strausbauch MA, Wettstein PJ, Lewin SR, Plana M, Rizza SA, Temesgen Z, Touloumi G, Freiberg M, Neaton J, Badley AD; INSIGHT SMART Study Group. Cummins NW, et al. Among authors: temesgen z. AIDS Res Hum Retroviruses. 2014 May;30(5):476-9. doi: 10.1089/AID.2013.0243. Epub 2014 Feb 14. AIDS Res Hum Retroviruses. 2014. PMID: 24344953 Free PMC article.

3

Twenty years of human immunodeficiency virus care at the Mayo Clinic: Past, present and future.

Cummins NW, Badley AD, Kasten MJ, Sampath R, Temesgen Z, Whitaker JA, Wilson JW, Yao JD, Zeuli J, Rizza SA. Cummins NW, et al. Among authors: temesgen z. World J Virol. 2016 May 12;5(2):63-7. doi: 10.5501/wjv.v5.i2.63. World J Virol. 2016. PMID: 27175350 Free PMC article. Review.

4

A National Survey of Provider's Preparedness to Care for Persons Living With HIV Aged ≥50 Years.

Sangarlangkarn A, Rizza SA, Mahmood M, Cummins NW, Temesgen Z. Sangarlangkarn A, et al. Among authors: temesgen z. J Contin Educ Health Prof. 2021 Jan 1;41(1):82-84. doi: 10.1097/CEH.0000000000000333. J Contin Educ Health Prof. 2021. PMID: 33433129

5

Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data.

Otto AO, Rivera CG, Zeuli JD, Temesgen Z. Otto AO, et al. Among authors: temesgen z. Cells. 2021 May 20;10(5):1263. doi: 10.3390/cells10051263. Cells. 2021. PMID: 34065305 Free PMC article. Review.

6

Hepatotoxicity of contemporary antiretroviral drugs.

Rivera CG, Otto AO, Zeuli JD, Temesgen Z. Rivera CG, et al. Among authors: temesgen z. Curr Opin HIV AIDS. 2021 Nov 1;16(6):279-285. doi: 10.1097/COH.0000000000000706. Curr Opin HIV AIDS. 2021. PMID: 34545037 Review.

7

Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection.

Zeuli JD, Rivera CG, Smith BL, Otto A, Temesgen Z. Zeuli JD, et al. Among authors: temesgen z. Drugs Today (Barc). 2022 Dec;58(12):555-576. doi: 10.1358/dot.2022.58.12.3448340. Drugs Today (Barc). 2022. PMID: 36651065

8

HIV screening in the health care setting: status, barriers, and potential solutions.

Rizza SA, MacGowan RJ, Purcell DW, Branson BM, Temesgen Z. Rizza SA, et al. Among authors: temesgen z. Mayo Clin Proc. 2012 Sep;87(9):915-24. doi: 10.1016/j.mayocp.2012.06.021. Mayo Clin Proc. 2012. PMID: 22958996 Free PMC article.

9

Daclatasvir for the treatment of chronic hepatitis C virus infection.

Temesgen Z, Rizza SA. Temesgen Z, et al. Drugs Today (Barc). 2015 May;51(5):277-88. doi: 10.1358/dot.2015.51.5.2312449. Drugs Today (Barc). 2015. PMID: 26097901 Review.

10

Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection.

Zeuli JD, Adie SK, Rizza SA, Temesgen Z. Zeuli JD, et al. Among authors: temesgen z. Drugs Today (Barc). 2015 Nov;51(11):629-43. doi: 10.1358/dot.2015.51.11.2414528. Drugs Today (Barc). 2015. PMID: 26744738 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page